NIZZARDO, MONICA
NIZZARDO, MONICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models
2025 E. Pagliari, M. Taiana, P. Manzini, L. Sali, L. Quetti, L. Bertolasi, S. Oldoni, V. Melzi, G. Comi, S. Corti, M. Nizzardo, F. Rizzo
iPSC-derived human cortical organoids display profound alterations of cellular homeostasis following SARS-CoV-2 infection and Spike protein exposure
2025 G. Cappelletti, L. Brambilla, S. Strizzi, F. Limanaqi, V. Melzi, M. Rizzuti, M. Nizzardo, I. Saulle, D. Trabattoni, S. Corti, M. Clerici, M. Biasin
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 D. Gagliardi, E. Pagliari, M. Meneri, V. Melzi, F. Rizzo, G.P. Comi, S.P. Corti, M.M. Taiana, M. Nizzardo
Generation of two hiPSC lines (UMILi027-A and UMILi028-A) from early and late-onset Congenital Central hypoventilation Syndrome (CCHS) patients carrying a polyalanine expansion mutation in the PHOX2B gene
2022 A.L. Cuadros Gamboa, R. Benfante, M. Nizzardo, T. Bachetti, P. Pelucchi, V. Melzi, C. Arzilli, M. Peruzzi, R.A. Reinbold, S. Cardani, A. Morrone, R. Guerrini, I. Zucchi, S. Corti, I. Ceccherini, R. Piumelli, N. Nassi, S. Di Lascio, D. Fornasari
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired
2022 M. Taiana, A. Govoni, S. Salani, N. Kleinschmidt, N. Galli, M. Saladini, S.B. Ghezzi, V. Melzi, M. Bersani, R. Del Bo, O. Muehlemann, E. Bertini, V. Sansone, E. Albamonte, S. Messina, F. Mari, E. Cesaroni, L. Porfiri, F.D. Tiziano, G.L. Vita, M. Sframeli, C. Bonanno, N. Bresolin, G. Comi, S. Corti, M. Nizzardo
Targeting PTB for Glia‐to‐Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
2022 M. Contardo, R. De Gioia, D. Gagliardi, G.P. Comi, L. Ottoboni, M. Nizzardo, S. Corti
Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
2021 M. Bersani, M. Rizzuti, E. Pagliari, M. Garbellini, D. Saccomanno, H.M. Moulton, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Morpholino oligomers ameliorates pathological hallmarks in C9orf72 cellular lines and mice
2021 M. Bersani, D. Gagliardi, M. Taiana, F. Biella, M. Nizzardo, S. Corti
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients
2021 C. Malacarne, M. Galbiati, E. Giagnorio, P. Cavalcante, F. Salerno, F. Andreetta, C. Cagnoli, M. Taiana, M. Nizzardo, S. Corti, V. Pensato, A. Venerando, C. Gellera, S. Fenu, D. Pareyson, R. Masson, L. Maggi, E. Dalla Bella, G. Lauria, R. Mantegazza, P. Bernasconi, A. Poletti, S. Bonanno, S. Marcuzzo
Human spinal cord-like organoids to model C9ORF72 ALS and test new therapies in vitro
2021 G. Costamagna, N. Galli, M. Rizzuti, B. Frizzi, F. Biella, M. Taiana, S. Ghezzi, I. Faravelli, G.P. Comi, M. Nizzardo, S. Corti
Neural stem cell transplantation for neurodegenerative diseases
2020 R. De Gioia, F. Biella, G. Citterio, F. Rizzo, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti
Changes in pathological phenotype of C9orf72 ALS iPSC-derived lines after treatment with Morpholino oligomers
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, S. Corti
Evaluation of Morpholino oligomers therapeutic efficacy in C9orf72 ALS iPSC-derived lines
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, N. Bresolin, G.P. Comi, S. Corti
Cell Penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
2020 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, D. Saccomanno, H.M. Moulton, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
CPPs-conjugated antisense nucleotides : a new therapeutic strategy for Spinal Muscular Atrophy symptomatic patients
2020 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, D. Saccomanno, N. Bresolin, G. Comi, S. Corti, M. Nizzardo
Optimization of AAV9 gene therapy for Spinal Muscular Atrophy with respiratory distress Type 1 using in vivo disease models
2020 E. Pagliari, P. Rinchetti, N. Galli, S. Ghezzi, M. Taiana, G. Comi, S. Corti, M. Nizzardo
Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow
2020 V. Mishra, D.B. Re, V. Le Verche, M.J. Alvarez, A. Vasciaveo, A. Jacquier, P. Doulias, T.M. Greco, M. Nizzardo, D. Papadimitriou, T. Nagata, P. Rinchetti, E.J. Perez-Torres, K.A. Politi, B. Ikiz, K. Clare, M.E. Than, S. Corti, H. Ischiropoulos, F. Lotti, A. Califano, S. Przedborski
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis
2020 A. Loffreda, M. Nizzardo, A. Arosio, M. Ruepp, R.A. Calogero, S. Volinia, M. Galasso, C. Bendotti, C. Ferrarese, C. Lunetta, M. Rizzuti, A. Ronchi, O. Mühlemann, L. Tremolizzo, S. Corti, S.M.L. Barabino
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 M. Nizzardo, M. Taiana, F. Rizzo, J. Aguila Benitez, J. Nijssen, I. Allodi, V. Melzi, N. Bresolin, G.P. Comi, E. Hedlund, S. Corti
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
2020 M.G.L. Perego, N. Galli, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti